Transfusion therapy in solid organ transplantation

G. Ramsey; L. A. Sherman

doi:10.1016/s0889-8588(18)30125-4

Transfusion therapy in solid organ transplantation

G. Ramsey^*, L. A. Sherman

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Numerous transfusion issues arise in the support of solid organ transplantation. ABO and HLA can cause graft rejection immunity or problems in transfusion support. Blood usage has been reduced by the use of erythropoietin in renal failure and aprotinin during liver transplants. Multifactorial coagulopathy during liver transplant surgery continues to be a challenge requiring close monitoring, however. The beneficial effect of transfusions on graft survival has lessened in recent years, but remains an area of active research.

Original language	English (US)
Pages (from-to)	1117-1129
Number of pages	13
Journal	Hematology/Oncology Clinics of North America
Volume	8
Issue number	6
DOIs	https://doi.org/10.1016/s0889-8588(18)30125-4
State	Published - Jan 1 1994

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/s0889-8588(18)30125-4

Fingerprint Dive into the research topics of 'Transfusion therapy in solid organ transplantation'. Together they form a unique fingerprint.

Cite this

@article{ec135ed104a34408ba8d8dd9a5a3ceeb,

title = "Transfusion therapy in solid organ transplantation",

abstract = "Numerous transfusion issues arise in the support of solid organ transplantation. ABO and HLA can cause graft rejection immunity or problems in transfusion support. Blood usage has been reduced by the use of erythropoietin in renal failure and aprotinin during liver transplants. Multifactorial coagulopathy during liver transplant surgery continues to be a challenge requiring close monitoring, however. The beneficial effect of transfusions on graft survival has lessened in recent years, but remains an area of active research.",

author = "G. Ramsey and Sherman, {L. A.}",

year = "1994",

month = jan,

day = "1",

doi = "10.1016/s0889-8588(18)30125-4",

language = "English (US)",

volume = "8",

pages = "1117--1129",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Transfusion therapy in solid organ transplantation

AU - Ramsey, G.

AU - Sherman, L. A.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Numerous transfusion issues arise in the support of solid organ transplantation. ABO and HLA can cause graft rejection immunity or problems in transfusion support. Blood usage has been reduced by the use of erythropoietin in renal failure and aprotinin during liver transplants. Multifactorial coagulopathy during liver transplant surgery continues to be a challenge requiring close monitoring, however. The beneficial effect of transfusions on graft survival has lessened in recent years, but remains an area of active research.

AB - Numerous transfusion issues arise in the support of solid organ transplantation. ABO and HLA can cause graft rejection immunity or problems in transfusion support. Blood usage has been reduced by the use of erythropoietin in renal failure and aprotinin during liver transplants. Multifactorial coagulopathy during liver transplant surgery continues to be a challenge requiring close monitoring, however. The beneficial effect of transfusions on graft survival has lessened in recent years, but remains an area of active research.

UR - http://www.scopus.com/inward/record.url?scp=0027971937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027971937&partnerID=8YFLogxK

U2 - 10.1016/s0889-8588(18)30125-4

DO - 10.1016/s0889-8588(18)30125-4

M3 - Review article

C2 - 7860440

AN - SCOPUS:0027971937

VL - 8

SP - 1117

EP - 1129

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 6

ER -